Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amn Healthcare Services (AMN) EBITDA Margin (2016 - 2025)

Amn Healthcare Services' EBITDA Margin history spans 16 years, with the latest figure at 1.03% for Q4 2025.

  • For Q4 2025, EBITDA Margin rose 2449.0% year-over-year to 1.03%; the TTM value through Dec 2025 reached 3.49%, up 142.0%, while the annual FY2025 figure was 3.49%, 142.0% up from the prior year.
  • EBITDA Margin reached 1.03% in Q4 2025 per AMN's latest filing, down from 4.63% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 9.35% in Q1 2022 to a low of 25.52% in Q4 2024.
  • Average EBITDA Margin over 5 years is 2.66%, with a median of 6.2% recorded in 2023.
  • Peak YoY movement for EBITDA Margin: crashed -2707bps in 2024, then soared 2449bps in 2025.
  • A 5-year view of EBITDA Margin shows it stood at 8.5% in 2021, then fell by -14bps to 7.28% in 2022, then plummeted by -79bps to 1.55% in 2023, then tumbled by -1747bps to 25.52% in 2024, then soared by 96bps to 1.03% in 2025.
  • Per Business Quant, the three most recent readings for AMN's EBITDA Margin are 1.03% (Q4 2025), 4.63% (Q3 2025), and 17.63% (Q2 2025).